Webinar: Talcum Powder and Ovarian Cancer

Posted on 11/11/2016Back

The Talcum Powder and Ovarian Cancer Trials

Why are juries punishing J&J?

Attorneys Stuart Goldenberg and Noah Lauricella shared their expertise regarding the talcum powder/ovarian cancer litigation alongside Jim Onder – a member of the trial team and local counsel representing plaintiffs in the ongoing St. Louis talcum powder trials. The webinar detailed the science behind the litigation that links Johnson & Johnson’s (J&J) talc-based products to ovarian cancer and shared the behind-the-scenes story of J&J’s response to the known dangers of such products when used for genital dusting. Internal documents first presented during the recent trials were discussed in order to demonstrate what may have led juries to award such large punitive damages in the three most recent verdicts. Such documents included:

  • A document showing J&J’s plan to target “curvy women” in the advertising of their talc-based products.
  • An internal training “monopoly board” used to show employees the importance of keeping the dangers of cosmetic talc under wraps and avoid both identification as a carcinogen and potential litigation.
  • A letter to J&J from a renowned toxicologist warning that they were “denying the obvious in the face of all evidence to the contrary.”

Check back shortly for access to the webinar audio or visit the Minnesota Association for Justice’s website for more information.

Category Dangerous Drugs